Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSTC0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,174
Award facts
- Contract value 100% obligated
- $74,173.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $74,173.95 by the Defense Logistics Agency (DLA) on September 19, 2025. The contract calls for the delivery of Entyvio 300 mg vials, a biologic medication used primarily for inflammatory bowel disease treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of October 10, 2025, with performance occurring at the contractor's Park Ridge, Illinois facility.
This award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, a $499.999 billion vehicle valid through November 2026 under the SPE2DB program. The IDC authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facility supply needs worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries to government agencies.
Quick answers
Who was awarded contract SPE2DB25FSTC0?
SPE2DB25FSTC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FSTC0 worth?
The government has obligated $74,174 on SPE2DB25FSTC0.
Is contract SPE2DB25FSTC0 an order under another contract?
Yes. SPE2DB25FSTC0 is a delivery order under SPE2DB22D9304, an indefinite delivery contract.
Was contract SPE2DB25FSTC0 competed?
The extent of competition for SPE2DB25FSTC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award